Last reviewed · How we verify

NCT03654690: eTest

eTest: Real-time, Remote Monitoring System for Home-based HIV Testing Among High-risk Men Who Have Sex With Men

Completed NA Results posted Last updated 10 April 2025
What this trial tests

NA trial testing HIV self-test in HIV Infections in 811 participants. Completed in 1 May 2023.

Timeline
23 January 2019
Primary endpoint
1 May 2023
1 May 2023

Quick facts

Lead sponsorBrown University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment811
Start date23 January 2019
Primary completion1 May 2023
Estimated completion1 May 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brown University

Who can join

18 and older, male only, with HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Model Adjusted Probability of Any HIV Testing Primary · 12 month study period

We used logistic regression with dummy-coded condition assignment as a predictor to test differences in outcomes across experimental conditions. A dummy-coded covariate indicating whether participants reported testing fewer than three times in the 3 years prior to enrolling was included in all models of HIV testing. We fit longitudinal mixed effects models for two outcomes, HIV testing and high-risk CAS events within a given follow-up period, given that these outcomes varied within participants across the study period. We specified distributions appropriate for each outcome (logistic for HIV

GroupValue95% CI
Control57.051.0 – 62.9
Standard Self-Testing91.087.9 – 94.6
Enhanced Self-Testing89.486.2 – 93.3
Model Adjusted Probabilities of Repeat HIV Testing (>1) Primary · 12 months

We used logistic regression with dummy-coded condition assignment as a predictor to test differences in outcomes across experimental conditions. A dummy-coded covariate indicating whether participants reported testing fewer than three times in the 3 years prior to enrolling was included in all models of HIV testing. We fit longitudinal mixed effects models for two outcomes, HIV testing and high-risk CAS events within a given follow-up period, given that these outcomes varied within participants across the study period. We specified distributions appropriate for each outcome (logistic for HIV

GroupValue95% CI
Control31.325.7 – 36.9
Standard Self-Testing79.474.5 – 84.3
Enhanced Self-Testing80.475.7 – 85.1
HIV Diagnoses Primary · 12 months

count of participants who were ultimately diagnosed with HIV during the course of the study

GroupValue95% CI
Control0
Standard Self-Testing4
Enhanced Self-Testing4
Model Predicted Probability of Receipt of a Prescription for Pre-exposure Prophylaxis (PrEP) Secondary · 12 month study period

We used logistic regression with dummy-coded condition assignment as a predictor to test differences in outcomes across experimental conditions. A binary variable reflecting whether participants had ever had a PrEP prescription in the past was included for the PrEP prescription model. We specified two-way interactions between these covariates and condition assignment in all models, but none were significant and were excluded.

GroupValue95% CI
Control2015 – 25
Standard Self-Testing1510 – 19
Enhanced Self-Testing1510 – 19
Model Predicted Probability of Receipt of Testing for Other Sexually-transmitted Infections Secondary · 12 months

We used logistic regression with dummy-coded condition assignment as a predictor to test differences in outcomes across experimental conditions. A dummy-coded covariate indicating whether participants reported testing fewer than three times in the 3 years prior to enrolling was included in all models of HIV testing. A similar covariate for STI testing was included in the STI testing model. We specified two-way interactions between these covariates and condition assignment in all models, but none were significant and were excluded.

GroupValue95% CI
Control4640 – 52
Standard Self-Testing4943 – 55
Enhanced Self-Testing5044 – 56
Average Predicted Number of High-risk Casual Anal Sex (CAS) Events With Partners of Unknown HIV and PrEP Status Secondary · 12 months

We used logistic regression with dummy-coded condition assignment as a predictor to test differences in outcomes across experimental conditions. We specified two-way interactions between these covariates and condition assignment in all models, but none were significant and were excluded. We fit longitudinal mixed effects models for two outcomes, HIV testing and high-risk CAS events within a given follow-up period, given that these outcomes varied within participants across the study period. We specified distributions appropriate for each outcome (logistic for HIV testing and negative binomial

GroupValue95% CI
Control2.030.5 – 3.6
Standard Self-Testing2.010.5 – 3.5
Enhanced Self-Testing1.46.3 – 2.6

Sponsor's own description

The proposed research will conduct a fully-powered efficacy trial of this approach in areas with large populations of AA and H/L MSM and high HIV incidence: Jackson, MS, Los Angeles, CA, and Boston, MA. High-risk MSM who have not tested for HIV in the last year will be recruited from MSM-oriented "hook-up" mobile apps, and assigned to receive either (1) HBST with post-test phone counseling/referral ("eTEST" condition), (2) "standard" HBST without active follow-up, or (3) reminders to get tested for HIV at a local clinic ("control" condition) at three month intervals over the course of 12 months. The investigators will explore the impact of the eTEST system on key outcomes, including rates of HIV testing, receipt of additional HIV prevention services, and PrEP initiation, compared with standard HBST or clinic-based testing reminders alone. The investigators will also explore the cost effectiveness of the eTEST system under various scenarios compared with relying on traditional, clinic-based testing alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of HIV self-test

Trials testing the same drug.

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

Other Brown University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03654690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing